Literature DB >> 34192450

Once-Weekly Semaglutide in Adults with Overweight or Obesity. Reply.

John P H Wilding1, Salvatore Calanna2, Robert F Kushner3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34192450     DOI： 10.1056/NEJMc2106918

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  [Obesity treatment-legal and illegal drugs and the future].

Authors:  H Hauner
Journal:  Internist (Berl)       Date:  2021-09-30       Impact factor: 0.743

2.  IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study.

Authors:  Linong Ji; Hongwei Jiang; Pei An; Huan Deng; Meng Liu; Li Li; Liqi Feng; Baili Song; Han Han-Zhang; Qingyang Ma; Lei Qian
Journal:  EClinicalMedicine       Date:  2021-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.